Social Costs Of Diseases Must Be Considered When Debating Costs Of Drug R&D
News Summary
U.S. News & World Report: The True Cost of Costly Drug Development Paul Howard, senior fellow and director of the Manhattan Institute’s Center for Medical Progress, and Yevgeniy Feyman, a fellow and deputy director of the Center for Medical Progress “…Focusing on the development costs, or even drug prices, without…